Evidence mapPaperPMID 42006146Full record

ArticleHuman mutation2026

SPP1 as a Critical Regulator of Cardiac Cell Reprogramming Following Myocardial Infarction Through Single-Cell Transcriptomic Analysis.

Rui Wang, Man Zhang, Xiaojun Liu, Zi Li, Xueqing Chen

Abstract read
In one paragraph

Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rui WangCardiovascular Department, Xiongan Xuanwu Hospital, Xiongan New District, China.ORCID https://orcid.org/0009-0009-3045-8876
Man ZhangCardiovascular Department, Xiongan Xuanwu Hospital, Xiongan New District, China.ORCID https://orcid.org/0009-0007-7160-5647
Xiaojun LiuCardiac Macrovascular Surgery Ward, Zibo Central Hospital, Zibo City, China, zbzxyy.com.ORCID https://orcid.org/0009-0009-4118-5287
Zi LiCardiac Macrovascular Surgery Ward, Zibo Central Hospital, Zibo City, China, zbzxyy.com.ORCID https://orcid.org/0009-0007-3952-672X
Xueqing ChenCardiac Macrovascular Surgery Ward, Zibo Central Hospital, Zibo City, China, zbzxyy.com.ORCID https://orcid.org/0009-0004-7390-3048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular mortality remains predominantly driven by acute myocardial infarction (AMI), necessitating comprehensive elucidation of mechanisms governing cardiomyocyte reprogramming for therapeutic advancement. Characterizing molecular dynamics throughout cardiac repair processes presents substantial methodological challenges. Methods: We employed a comprehensive analytical framework combining bulk and single-cell RNA sequencing datasets from AMI patients, utilizing 26 distinct machine learning algorithms to delineate critical regulatory gene signatures associated with cardiac repair. Gene prioritization was achieved through differential expression profiling coupled with consensus clustering methodologies. Functional validation experiments in H9c2 cardiomyoblast cellular models demonstrated that enhanced SPP1 expression is associated with augmented cellular viability and stimulated cardioprotective factor release, though these findings require validation in more physiologically relevant systems. Results: Machine learning architectures successfully identified robust cardiomyocyte reprogramming signatures correlating with cardiac functional restoration. Consensus clustering analysis of 276 genes revealed two phenotypically distinct repair subtypes demonstrating divergent recovery trajectories ( Conclusion: This machine learning-driven approach successfully identified novel candidate prognostic biomarkers and potential therapeutic targets for cardiac repair interventions, substantially advancing mechanistic understanding of postinfarction cardiac remodeling processes. These findings generate testable hypotheses requiring validation in independent clinical cohorts and more physiologically relevant experimental systems.

Indexed as

Cellular ReprogrammingMyocardial InfarctionMyocytes, CardiacOsteopontinSingle-Cell AnalysisTranscriptomeAnimalsGene Expression ProfilingHumansMachine LearningSingle-Cell Gene Expression AnalysisOsteopontincardiac cell reprogrammingcomputational biologymyocardial infarctionregenerative medicinesingle-cell transcriptomicsSPP1 biomarker

Identifiers

PMID42006146
PMCPMC13090538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.